In view to roll out the vaccination drive in Nepal, the Nepalese authority on Friday granted approval to the India made vaccine ‘Covishield’ to tackle the emergency situation within the country. As per government data the country has reported 2,66,816 Covid-19 cases and 1,948 deaths since the outbreak.
Country’s Department of Drug Administration released a statement saying, “Conditional permission has been granted for emergency use authorization of COVISHIELD vaccine against COVID-19 in Nepal”.
The emergency approval to the AstraZeneca’s Covishield manufactured by the Serum Institute of India came during the ongoing sixth meeting of the India-Nepal joint Commission meeting between the Nepal’s foreign minister Pradeep Kumar Gyawali and India’s External affairs minister S Jaishankar in Delhi. As per Ministry of External Affairs, the Nepalese counterpart also congratulated India on successful production of the two vaccines and requested for early supply of vaccines to Nepal.